Skip to the main content
Cheque Size$100K to $2M
Stages2
Industries15
Markets33
Stated Portfolio28
Operating Since2020 (6y)

About ZAKA VC

ZAKA VC is a family venture house investing in early-stage tech startups globally, focusing on pre-seed and seed stages, primarily in Europe. Operating from Prague and Bratislava, the firm has invested in over 80 companies across five continents, with a current fund size of €17 million. Their portfolio includes companies like Mews, Verne Robotics, and Avelis Health. The firm's investment strategy emphasizes sectors such as Healthcare & Life Sciences, DeepTech, and Industrial Tech. ZAKA VC seeks entrepreneurs with global ambition and supports them by creating a bridge between North America and Europe. They have a presence in cities including Silicon Valley, London, Prague, and Bratislava. In July 2024, ZAKA VC launched its first fund, ZAKA VC Fund I, with a size of €15 million, aimed at supporting early-stage startups across Europe and the US. The fund focuses on B2B software and cross-sectional applications of AI in B2B, biotech, and health tech. Notable investments include ExcepGen, Sensible Biotechnologies, Miros.ai, Supliful, Lime Therapeutics, and Webel.

Geographical Focus

African markets1

Other stated markets32

United StatesUnited KingdomCanadaGermanyAustraliaIndiaSwitzerlandSpainIrelandAustriaTurkeyNetherlandsMontenegroHungaryBosnia and HerzegovinaKosovoSloveniaCroatiaFinlandPolandCzech RepublicSlovakiaSerbiaRomaniaBulgariaSri LankaEstoniaLatviaNorth MacedoniaAlbaniaMoldovaKazakhstan

Requirements

Entrepreneurs with global ambition, Early-stage technology companies, Pre-seed and seed stages, Focus on sectors like Healthcare & Life Sciences, DeepTech, Industrial Tech, E-Commerce, PropTech, ConTech, EdTech, Fintech, Enterprise Software, HR Tech, Mobility, Biotech, Health Tech, and Artificial Intelligence, Early-stage tech startups in Healthcare & Life Sciences, DeepTech, Industrial Tech, E-Commerce, PropTech, ConTech, EdTech, Fintech, Enterprise Software, HR Tech, Mobility sectors

Stated Portfolio28

Mews
Creasallis
ExcepGen
Sensible Biotechnologies
Miros.ai
Supliful
Lime Therapeutics
Webel
Eigen Therapeutics
Bluejay
Mbodi AI
Inversion Semiconductor
HexemBio
Momentous Therapeutics
Promakhos
Superlinked
ExoMatter
Sutro
Yenmo
edgetrace
Verne Robotics
Avelis Health
b-12
Nephrogen
Bullseye Biosciences
Alixia Therapeutics
Sygaldry Technologies
Adentris

As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.